Arecor Therapeutics plc (LON:AREC – Get Free Report) shares reached a new 52-week low during mid-day trading on Friday . The company traded as low as GBX 50 ($0.63) and last traded at GBX 52 ($0.66), with a volume of 3900 shares trading hands. The stock had previously closed at GBX 52.50 ($0.67).
Arecor Therapeutics Trading Down 1.0 %
The stock has a market cap of £19.63 million, a price-to-earnings ratio of -1.84 and a beta of -0.18. The company has a quick ratio of 6.24, a current ratio of 1.37 and a debt-to-equity ratio of 5.51. The business has a 50-day moving average of GBX 62.15 and a 200-day moving average of GBX 71.84.
Arecor Therapeutics Company Profile
Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products.
Recommended Stories
- Five stocks we like better than Arecor Therapeutics
- How to Use High Beta Stocks to Maximize Your Investing Profits
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- ETF Screener: Uses and Step-by-Step Guide
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- What is the Shanghai Stock Exchange Composite Index?
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
